LONA LeonaBio, Inc.
Healthcare$10.33+2.58%ClosedMarket Cap: $40.7M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
3.99
P/S
0.00
EV/EBITDA
-0.08
DCF Value
$15.07
FCF Yield
-127.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-381.0%
ROA
-180.8%
ROIC
-168.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-17.2M | $-32.9M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-78.6M | $-82.9M | $— | — |
| FY null | $0.00 | -Infinity% | $-102.3M | $-105.6M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-6.9M | $-6.6M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-7.3M | $-7.0M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-9.5M | $-9.1M | $— | — |
| Q4 null | $0.00 | NaN% | $-15.6M | $-15.0M | $— | — |
| FY null | $0.00 | NaN% | $-100.9M | $-96.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-29.6M | $-28.7M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-28.0M | $-26.9M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-27.7M | $-26.3M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-29.0M | $-27.3M | $-7.20 | — |